IRadimed
IRMD
#5603
Rank
โ‚น109.42 B
Marketcap
โ‚น8,602
Share price
0.96%
Change (1 day)
87.31%
Change (1 year)
Categories

Revenue for IRadimed (IRMD)

Revenue in 2025 (TTM): โ‚น6.96 Billion

According to IRadimed's latest financial reports the company's current revenue (TTM ) is โ‚น7.25 Billion. In 2024 the company made a revenue of โ‚น6.28 Billion an increase over the revenue in the year 2023 that were of โ‚น5.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for IRadimed from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น6.96 B10.83%
2024 โ‚น6.28 B15.12%
2023 โ‚น5.45 B23.74%
2022 โ‚น4.41 B41.72%
2021 โ‚น3.11 B34.17%
2020 โ‚น2.31 B-15.55%
2019 โ‚น2.74 B29.05%
2018 โ‚น2.12 B44.42%
2017 โ‚น1.47 B-33.26%
2016 โ‚น2.20 B5.18%
2015 โ‚น2.09 B111.64%
2014 โ‚น0.99 B41.6%
2013 โ‚น0.70 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AtriCure
ATRC
โ‚น46.69 B 543.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NuVasive
NUVA
โ‚น110.47 B 1,423.05%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
โ‚น406.83 B 5,509.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
โ‚น530.07 B 7,208.05%๐Ÿ‡บ๐Ÿ‡ธ USA